Evotec SE (EVO)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-11-09 | Phase1 Readout | — |
| 2027-04-01 | Phase1 Readout | — |
Active Clinical Trials (3)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT04084145 | National Unified Renal Translation Research Enterprise - Chronic Kidney Disease | OTHER | Active Not Recruiting | 3,004 |
| NCT06943378 | Ph1, Randomized, Double-Blind and Controlled, Dose Escalation and Expansion Study to Assess the Safety and Pharmacokinet... | PHASE1 | Active Not Recruiting | 104 |
| NCT07595458 | Phase 1 Study on the Safety, Tolerability, and Pharmacokinetics of JST-018 in Healthy Adults | PHASE1 | Recruiting | 48 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.